Molecularly, elevated Crh promotes HPA axis hyperactivation, while reduced Fkbp5 may enhance glucocorticoid receptor sensitivity, leading to prolonged transcriptional effects of corticosterone and likely contributing to the observed hypercortisolemia. The gene discussed is FKBP5; the disease is adrenal gland hyperfunction.